Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis
Open Access
- 29 May 2018
- journal article
- research article
- Published by Springer Nature in BioDrugs
- Vol. 32 (3) , 281-291
Abstract
Multi-criteria decision analysis (MCDA) is a tool that systematically considers multiple factors relevant to health decision-making. The aim of this study was to use an MCDA to assess the value of dupilumab for severe atopic dermatitis compared with secukinumab for moderate to severe plaque psoriasis in Spain.Keywords
This publication has 55 references indexed in Scilit:
- Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitisThe Journal of Dermatology, 2013
- Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011PLOS ONE, 2012
- Health care priority setting in Norway a multicriteria decision analysisBMC Health Services Research, 2012
- Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in CanadaBMC Health Services Research, 2011
- Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic conceptsJournal of Allergy and Clinical Immunology, 2011
- Atopic dermatitis in older patients: particular pointsJournal of the European Academy of Dermatology and Venereology, 2010
- Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiencesHealth Policy, 2010
- Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decisionmaking framework to growth hormone for Turner syndrome patientsCost Effectiveness and Resource Allocation, 2010
- The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative processJournal of Medical Ethics, 2008
- A prospective evaluation of the cost of psoriasis in Spain (EPIDERMA project: Phase II)Journal of the European Academy of Dermatology and Venereology, 2006